[HTML][HTML] Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
KA Morgan, CW Wichmann, LD Osellame, Z Cao… - Chemical …, 2024 - pubs.rsc.org
Selective antibody targeted delivery of α particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
KA Morgan, CW Wichmann, LD Osellame… - Chemical …, 2024 - pubmed.ncbi.nlm.nih.gov
Selective antibody targeted delivery of α particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
KA Morgan, C Wichmann, A Osellame, Z Cao, N Guo… - 2024 - opal.latrobe.edu.au
Selective antibody targeted delivery of α particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX†† Electronic supplementary information (ESI) available. See
K Morgan, C Wichmann, L Osellame, Z Cao… - Chemical …, 2024 - europepmc.org
Selective antibody targeted delivery of α particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
KA Morgan, CW Wichmann, LD Osellame, Z Cao… - Chemical Science, 2024 - Elsevier
Selective antibody targeted delivery of α particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …
[HTML][HTML] Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
KA Morgan, CW Wichmann, LD Osellame, Z Cao… - Chemical …, 2024 - ncbi.nlm.nih.gov
Selective antibody targeted delivery of α particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX.
KA Morgan, CW Wichmann, LD Osellame, Z Cao… - Chemical …, 2024 - europepmc.org
Selective antibody targeted delivery of α particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …
[PDF][PDF] Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
KA Morgan, CW Wichmann, LD Osellame, Z Cao… - opal.latrobe.edu.au
Selective antibody targeted delivery of a particle emitting actinium-225 to tumors has
significant therapeutic potential. This work highlights the design and synthesis of a new …
significant therapeutic potential. This work highlights the design and synthesis of a new …